Johnson & Johnson (JNJ) insider trading

By person

13 insiders · 33 transactions

52.6×

J. Duato holds 52.6 times base salary in stock. $84.30M of shares against $1.60M in salary for 2025.

Salary from the company's own proxy. The shares are what J. Duato last reported holding, valued at $274.74, the price Common Stock was last bought or sold at on the open market here, on 2 Sep 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Joaquin Duato

CEO and Chairman of the Board

—

$66.84M (6)

−$66.84M

306,819

0.0127%

$84.30M

−15.5%

Joseph J Wolk

Exec VP, CFO

—

$21.77M (4) scheduled

−$21.77M

14,000

0.0006%

$3.85M

—

James D. Swanson

EVP, CIO

—

$15.11M (3) scheduled

−$15.11M

25,698

0.0011%

$7.06M

+76.3%

Timothy Schmid

EVP, WW Chair, MedTech

—

$15.08M (5) scheduled

−$15.08M

26,251

0.0011%

$7.21M

+89.6%

John C Reed

EVP, Innovative Medicine, R&D

—

$13.11M (3) scheduled

−$13.11M

24,911

0.0010%

$6.84M

+70.9%

Vanessa Broadhurst

EVP, Global Corp Affairs

—

$7.30M (2) scheduled

−$7.30M

23,003

0.0010%

$6.32M

+16.0%

Elizabeth Forminard

EVP, Chief Legal Officer

—

$4.09M (2) scheduled

−$4.09M

16,994

0.0007%

$4.67M

+103.8%

Jennifer L Taubert

EVP, WWC. Innovative Medicine

—

$3.95M (1) scheduled

−$3.95M

194,451

0.0081%

$53.42M

+25.6%

Kathryn E Wengel

EVP, Chief TO and Risk Officer

—

$2.41M (1) scheduled

−$2.41M

114,288

0.0047%

$31.40M

+38.9%

Robert J Decker

VP Corporate Controller

—

$1.01M (1) scheduled

−$1.01M

23,682

0.0010%

$6.51M

+24.8%

John G Morikis

Director

$257.69K (1)

—

+$257.69K

1,849

<0.0001%

$507.86K

+208.9%

Kristen Mulholland

EVP, Chief HR Officer

—

19,830

0.0008%

$5.45M

+69.6%

Mark A Weinberger

Director

—

1,000

<0.0001%

$274.74K

—

Johnson & Johnson

What the insiders did Net selling

By person